OTC Markets OTCPK - Delayed Quote USD

Kobayashi Pharmaceutical Co., Ltd. (KBYPF)

Compare
37.43
0.00
(0.00%)
At close: January 16 at 3:00:00 PM EST
Loading Chart for KBYPF
DELL
  • Previous Close 37.43
  • Open 37.43
  • Bid 34.64 x 40000
  • Ask 38.55 x 40000
  • Day's Range 37.43 - 37.43
  • 52 Week Range 31.81 - 55.28
  • Volume 100
  • Avg. Volume 11
  • Market Cap (intraday) 2.783B
  • Beta (5Y Monthly) 0.25
  • PE Ratio (TTM) 42.53
  • EPS (TTM) 0.88
  • Earnings Date Feb 10, 2025
  • Forward Dividend & Yield 0.75 (2.01%)
  • Ex-Dividend Date Dec 27, 2024
  • 1y Target Est --

Kobayashi Pharmaceutical Co., Ltd., together with its subsidiaries, engages in the manufacture and sale of OTC pharmaceuticals, guasi-drugs, deodorizing air fresheners, and sanitary products in Japan and internationally. The company offers Ammeltz, an anti-inflammatory pain relief medicine; Dent, an effervescent denture cleaning agent; Ekitai Bluelet Okudake, a toilet bowl cleaner; Naicitol, a Chinese medicine; BreathCare, an oral breath freshener capsule; Netsusama sheet, a cooling gel sheet; and deodorizing air freshener, lens cleaner, cooling gel sheets, and oral hygiene products. It also manufactures and sells pharmaceuticals, cosmetics, and health foods; and manufactures and sells synthetic resin products; markets nutritional supplements and skin care products through mail orders; and sells skincare products, daily necessities, and health foods, as well as manufactures body warmers. In addition, the company engages in transportation, real estate management, and advertising planning and production businesses; manufacture of sanitary and paper products; and asset management. Kobayashi Pharmaceutical Co., Ltd. was founded in 1886 and is headquartered in Osaka, Japan.

www.kobayashi.co.jp

3,534

Full Time Employees

December 31

Fiscal Year Ends

Recent News: KBYPF

View More

Performance Overview: KBYPF

Trailing total returns as of 1/17/2025, which may include dividends or other distributions. Benchmark is

.

YTD Return

KBYPF
0.00%
Nikkei 225
3.62%

1-Year Return

KBYPF
262.96%
Nikkei 225
8.38%

3-Year Return

KBYPF
1,069,260.40%
Nikkei 225
35.71%

5-Year Return

KBYPF
31,097,075.00%
Nikkei 225
59.94%

Compare To: KBYPF

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: KBYPF

View More

Valuation Measures

Annual
As of 1/17/2025
  • Market Cap

    2.76B

  • Enterprise Value

    2.43B

  • Trailing P/E

    42.63

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    2.57

  • Price/Book (mrq)

    2.11

  • Enterprise Value/Revenue

    2.24

  • Enterprise Value/EBITDA

    27.51

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    6.03%

  • Return on Assets (ttm)

    5.56%

  • Return on Equity (ttm)

    4.86%

  • Revenue (ttm)

    168.8B

  • Net Income Avi to Common (ttm)

    10.18B

  • Diluted EPS (ttm)

    0.88

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    51.67B

  • Total Debt/Equity (mrq)

    0.47%

  • Levered Free Cash Flow (ttm)

    --

Research Analysis: KBYPF

View More

Company Insights: KBYPF

Research Reports: KBYPF

View More

People Also Watch